An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression.
Yu L, Allen R, Jia L, Sun T, Isakoff SJ, Scherrer-Crosbie M, Kehlmann AM, Zheng H, Ly A, Walmsley CS, Hesler K, Varasteh AN, Pinto CJ, McLoughlin DE, Wu W, Wang X.
Yu L, et al. Among authors: sun t.
Front Oncol. 2022 May 3;12:809715. doi: 10.3389/fonc.2022.809715. eCollection 2022.
Front Oncol. 2022.
PMID: 35592673
Free PMC article.